Sana Biotechnology Inc (SANA) Stock Price, Quote & News

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 701 7914

Website: www.sana.com

Address:

188 East Blaine Street, Suite 400, Seattle, United States

LoveRetailFroth Aug. 19 at 2:03 PM

$SANA HIP REVOLUTIONARY! Squeeze will be epic here🚀

0 · Reply

LoveRetailFroth Aug. 19 at 11:57 AM

$RXRX Good Morning my Bio 💎s ☕️ $TEM $SANA $AMLX

0 · Reply

BBraggHillBoys Aug. 19 at 10:46 AM

$SANA dilution absorption going well, but buyers are not overwhelming new supply... A push and hold through $3.70 today and then a move through $3.83 with 3+mill volume would be meaningful.

1 · Reply

LoveRetailFroth Aug. 18 at 2:31 PM

$RXRX Good morning 💎s ☕️ Was busy with my 17 month investment in $AMLX bearing great fruit😂 $SANA $VIVO

0 · Reply

LoveRetailFroth Aug. 18 at 11:20 AM

$AMLX $NEWH $RXRX $SANA

0 · Reply

cta7978 Aug. 18 at 3:15 AM

$SANA Are we going to see a pop end of August if Mayo whether takes the option or not? Another $25 million dilution at $3.33, lower than current price, but on the flip side shows further confidence from Mayo. Makes sense Mayo will wait for the last minute. Are investors waiting for this deadline to pass?

1 · Reply

BBraggHillBoys Aug. 17 at 2:42 PM

$SANA a push through $3.68 with increasing volume would be a meaningful confirmation.

0 · Reply

LoveRetailFroth Aug. 17 at 2:00 PM

$AMLX Good Morning my 💎 s☕️ $ARBE $VIVO $SANA

0 · Reply

LoveRetailFroth Aug. 15 at 3:02 PM

$RXRX Good Saturday Morning Folks, a flat week for my portfolio. BIG boys are accumulating. Slow & then🌋 $VIVO $ARBE same deal slown & explosion. $SANA is a 💎. HIP is transformational. Enjoy the weekend & GL.

0 · Reply

cta7978 Aug. 14 at 6:45 PM

$SANA Back in heavy.

1 · Reply

Sana Biotechnology price target lowered to $6 from $7 at BofA

2026-08-10T20:46:01.000Z - 8 days ago

Sana Biotechnology reports Q2 EPS (13c), consensus (12c)

Aug 10, 2026, 4:00 PM EDT - 8 days ago

Sana Biotechnology Earnings release: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 8 days ago

Sana Biotechnology Quarterly report: Q2 2026

Aug 10, 2026, 7:00 AM EDT - 9 days ago

Sana Biotechnology Slides: Corporate presentation

Jul 29, 2026, 10:09 AM EDT - 21 days ago

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

2026-07-13T13:30:18.000Z - 5 weeks ago

Sana Biotechnology announces publication of long-term diabetes data

Jul 13, 2026, 8:00 AM EDT - 5 weeks ago

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Jul 1, 2026, 9:00 AM EDT - 7 weeks ago

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Jun 9, 2026, 4:00 PM EDT - 2 months ago

Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 3, 2026, 9:20 AM EDT - 2 months ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 4:05 PM EDT - 2 months ago

Sana Biotechnology to Present at June 2026 Investor Conferences

May 15, 2026, 9:00 AM EDT - 3 months ago

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

2026-05-12T22:28:22.000Z - 3 months ago

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

May 12, 2026, 5:20 PM EDT - 3 months ago

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

2026-05-11T20:42:28.000Z - 3 months ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

May 11, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Slides: Corporate presentation

2026-05-11T17:02:47.000Z - 3 months ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

May 5, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Apr 27, 2026, 4:30 PM EDT - 4 months ago

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing

2026-04-14T13:23:10.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-13T20:18:08.000Z - 4 months ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Sana Biotechnology Slides: Corporate presentation

2026-03-13T13:10:51.000Z - 5 months ago

Sana announces follow-up results from first-in-human study transplanting UP421

Mar 11, 2026, 1:40 PM EDT - 5 months ago

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

2026-03-03T22:25:38.000Z - 6 months ago

Sana Biotechnology files automatic mixed securities shelf

2026-03-03T21:25:24.000Z - 6 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

Mar 3, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Annual report: Q4 2025

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Earnings release: Q4 2025

Mar 2, 2026, 1:10 PM EST - 6 months ago

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences

2026-02-17T14:16:15.000Z - 6 months ago

Sana Biotechnology appoints Piper as EVP, CFO

Jan 14, 2026, 12:45 PM EST - 7 months ago

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:00 PM EST - 7 months ago

Sana Biotechnology Slides: Corporate presentation

Jan 7, 2026, 4:26 PM EST - 7 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

2026-01-06T15:25:24.000Z - 8 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA

2025-12-08T14:05:59.000Z - 9 months ago

Sana Biotechnology announces publication of in vivo gene editing

Dec 8, 2025, 9:00 AM EST - 9 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 3, 2025, 2:35 PM EST - 9 months ago

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 2, 2025, 2:30 PM EST - 9 months ago

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Nov 24, 2025, 4:05 PM EST - 9 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 12, 2025, 1:30 PM EST - 9 months ago

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

2025-11-06T23:25:54.000Z - 10 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Quarterly report: Q3 2025

Nov 5, 2025, 6:00 PM EST - 10 months ago

Sana Biotechnology Slides: Investor Presentation

2025-10-30T10:25:41.000Z - 10 months ago

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

2025-10-15T17:45:20.000Z - 10 months ago

Sana Biotechnology strength attributed to EMJ Capital long call

2025-09-24T11:45:09.000Z - 11 months ago

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

Sep 9, 2025, 9:30 AM EDT - 1 year ago

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 11:30 AM EDT - 1 year ago

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 2, 2025, 3:15 PM EDT - 1 year ago

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

Aug 28, 2025, 8:00 AM EDT - 1 year ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Aug 26, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 20, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q2 2025

Aug 6, 2025, 11:24 PM EDT - 1 year ago

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 4:38 PM EDT - 1 year ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Aug 4, 2025, 11:35 AM EDT - 1 year ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Jun 23, 2025, 10:05 AM EDT - 1 year ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 10, 2025, 8:40 AM EDT - 1 year ago

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 4, 2025, 2:35 PM EDT - 1 year ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Sana Biotechnology Slides: Corporate Presentation

May 28, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at June 2025 Investor Conferences

May 13, 2025, 12:20 PM EDT - 1 year ago

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 8, 2025, 4:00 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q1 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Proxy statement: Proxy Filing

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Sana Biotechnology Annual report: Q4 2024

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q4 2024

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

LoveRetailFroth Aug. 19 at 2:03 PM

$SANA HIP REVOLUTIONARY! Squeeze will be epic here🚀

0 · Reply

LoveRetailFroth Aug. 19 at 11:57 AM

$RXRX Good Morning my Bio 💎s ☕️ $TEM $SANA $AMLX

0 · Reply

BBraggHillBoys Aug. 19 at 10:46 AM

$SANA dilution absorption going well, but buyers are not overwhelming new supply... A push and hold through $3.70 today and then a move through $3.83 with 3+mill volume would be meaningful.

1 · Reply

LoveRetailFroth Aug. 18 at 2:31 PM

$RXRX Good morning 💎s ☕️ Was busy with my 17 month investment in $AMLX bearing great fruit😂 $SANA $VIVO

0 · Reply

LoveRetailFroth Aug. 18 at 11:20 AM

$AMLX $NEWH $RXRX $SANA

0 · Reply

cta7978 Aug. 18 at 3:15 AM

1 · Reply

BBraggHillBoys Aug. 17 at 2:42 PM

$SANA a push through $3.68 with increasing volume would be a meaningful confirmation.

0 · Reply

LoveRetailFroth Aug. 17 at 2:00 PM

$AMLX Good Morning my 💎 s☕️ $ARBE $VIVO $SANA

0 · Reply

LoveRetailFroth Aug. 15 at 3:02 PM

0 · Reply

cta7978 Aug. 14 at 6:45 PM

$SANA Back in heavy.

1 · Reply

Y007 Aug. 14 at 5:48 PM

$SANA

0 · Reply

NotHopeJustFacts Aug. 14 at 3:34 PM

$SANA $10M per month to operate while doing research as any high schooler ? this will take many YEARS in plural and thus many dilutions before they tell you that didn't make expectations

1 · Reply

LoveRetailFroth Aug. 14 at 2:11 PM

$RXRX Good Morning ☕️ I am a marathon 🏃‍♂️. $ARBE $SANA $VIVO

0 · Reply

brut_2_3 Aug. 14 at 12:39 PM

$SANA BofA Securities Adjusts Sana Biotechnology Price Target to $6 From $7

0 · Reply

retireddprof Aug. 14 at 11:06 AM

$SANA FYI a possible future successful encapsulation approach https://dx.doi.org/10.1038/s41551-026-01775-8

0 · Reply

Poshfox Aug. 12 at 8:06 PM

$SANA hmm. All these up days got us close to the 70%rsi resistance. Needed a down day to to push it higher. So after hitting a new 1 month high on another big buy, we close the last second .02 down. Almost like something or someone is shepherding this stock higher.

0 · Reply

BBraggHillBoys Aug. 12 at 12:20 PM

$SANA I'm already up 8% on this bullish confirmation; I'm not trimming yet.

0 · Reply

LoveRetailFroth Aug. 11 at 9:26 PM

$SANA SG-293 Yuge. Primary market, NHL -15 billion. Secondary market- Autoimmune diseases - 150 billion 🚀🍺

0 · Reply

Y007 Aug. 11 at 8:45 PM

$SANA Mayos involvement only reason this company made sense and now with its disappointing ER major red flags have emerged… 25 Million is pocket change to Mayo.. The fact that they are letting the clock run out all the way to the August 31 deadline proves this isn't about the money… The primary goal for Sana this year was to cleanly file their IND application for their lead diabetes project. By stalling on that application, Sana has missed a critical operational checkpoint… Sana board is in complete dissent as they have been keeping its lights rolling by aggressively printing new shares and dumping them onto retail investors via their At-The-Market facility. Mayo will not throw good money after bad if they see that management is using dilution to stay afloat while their actual drug development timeline is moving backwards. Finally their main project is getting absolutely crushed in its race against a Goliath in Vertex Mayo walks away this thing is a wrap by September

6 · Reply

Lowboy66 Aug. 11 at 8:19 PM

$SANA Mmmmmmmmm

0 · Reply

LoveRetailFroth Aug. 11 at 7:49 PM

$SANA 🚀

0 · Reply

mirko_papuga Aug. 11 at 5:53 PM

$SANA Was pleased with the Q2/26 report. To date Mayo has not elected the second tranche of shares, I suspect they may closer to the end of the month. Suspect IND will be submitted in next 90 days. Picked up extra 555 shares today. Total now at varying costs 51,254 shares and holding. Short position has increased significantly at July 15, 20206, potential short squeeze in the future.

1 · Reply

Market Cap	1.10B
Revenue (ttm)	0.00
Net Income (ttm)	-244.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,092,600
Avg Vol	3,098,962
Day's Range	N/A - N/A
Shares Out	299.36M
Stochastic %K	52%
Beta	2.16
Analysts	Strong Sell
Price Target	$9.38